Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-၀.၂၁%
၁,၀၉၁.၅၁
-၂.၃၀
-၀.၂၁%
—၁,၀၉၃.၈၁၁,၀၉၆.၅၂၁,၁၀၀.၂၂၁,၀၉၁.၅၁——
SIXC
Communications
SIXC
Communications
SIXC
+၀.၂၂%
၆၁၀.၁၁
+၁.၃၄
+၀.၂၂%
—၆၀၈.၇၇၆၀၈.၇၇၆၁၂.၉၇၆၀၈.၇၇——
SIXE
Energy
SIXE
Energy
SIXE
-၁.၃၄%
၁,၂၃၇.၉၈
-၁၆.၈၃
-၁.၃၄%
—၁,၂၅၄.၈၁၁,၂၅၃.၀၁၁,၂၅၃.၈၇၁,၂၂၆.၃၃——
SIXI
Industrials
SIXI
Industrials
SIXI
-၀.၉၃%
၁,၇၄၄.၇၁
-၁၆.၄၀
-၀.၉၃%
—၁,၇၆၁.၁၁၁,၇၆၄.၂၇၁,၇၆၆.၈၈၁,၇၄၄.၇၁——
SIXM
Financials
SIXM
Financials
SIXM
-၀.၃၇%
၆၄၀.၁၈
-၂.၄၀
-၀.၃၇%
—၆၄၂.၅၈၆၄၄.၈၇၆၄၈.၄၈၆၄၀.၁၈——
SIXR
Staples
SIXR
Staples
SIXR
-၀.၁၈%
၈၄၉.၅၈
-၁.၅၅
-၀.၁၈%
—၈၅၁.၁၃၈၅၅.၆၆၈၅၈.၇၅၈၄၅.၅၆——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-၀.၂၃%
၂၁၇.၄၈
-၀.၅၀
-၀.၂၃%
—၂၁၇.၉၈၂၁၇.၉၈၂၁၈.၆၅၂၁၆.၈၈——
SIXT
Technology
SIXT
Technology
SIXT
+၁.၅၂%
၃,၂၆၀.၆၉
+၄၈.၈၆
+၁.၅၂%
—၃,၂၁၁.၈၃၃,၂၂၇.၂၁၃,၂၆၈.၃၈၃,၂၂၆.၅၅——
SIXU
Utilities
SIXU
Utilities
SIXU
-၀.၆၉%
၉၄၂.၄၅
-၆.၅၃
-၀.၆၉%
—၉၄၈.၉၈၉၄၈.၅၈၉၅၇.၈၃၉၄၁.၉၇——
SIXV
Health care
SIXV
Health care
SIXV
-၀.၅၂%
၁,၄၆၆.၈၀
-၇.၇၂
-၀.၅၂%
—၁,၄၇၄.၅၂၁,၄၇၉.၀၃၁,၄၈၁.၀၄၁,၄၆၆.၈၀——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+၀.၂၂%
၂,၃၉၇.၅၀
+၅.၃၈
+၀.၂၂%
—၂,၃၉၂.၁၂၂,၃၉၆.၉၅၂,၄၂၁.၂၂၂,၃၈၂.၃၂——
Q1 2026 earnings • released • EPS miss -၄.၅၄% • Revenue beat +၀.၃၃%
See results
NOT:ETR
Novartis
၁၂၆.၄၄ €
+၃.၀၅%
(+၃.၇၄) 1D
ဧ ၃၀, GMT+၂ ၁၇:၃၅:၅၇  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for NOT...
Open
၁၂၂.၆၀ €
High
၁၂၆.၅၂ €
Low
၁၂၂.၆၀ €
Mkt. cap
ဋေ ၂.၉၆ သ
Avg. vol.
၂.၁၁ ထောင်
Volume
၁.၀၃ ထောင်
52-wk high
၁၄၄.၁၂ €
52-wk low
၉၄.၀၀ €
No. of employees
၈ သောင်း
News stories
From sources across the web
The Center Square
The Center Square
·
ပြီးခဲ့သည့် ၁ ရက်
Swiss drugmaker spending portion of $23B investment in Morrisville
Yahoo Finance
Yahoo Finance
·
ပြီးခဲ့သည့် ၁ ရက်
Here's What Analysts Are Forecasting For Novartis AG (VTX:NOVN) After Its First-Quarter Results
Yahoo Finance
Yahoo Finance
·
ပြီးခဲ့သည့် ၂ ရက်
PTC Therapeutics (PTCT) Is Down 5.1% After New Votoplam Huntington’s Data And Novartis Milestone
ABC11 Raleigh-Durham
ABC11 Raleigh-Durham
·
ပြီးခဲ့သည့် ၂ ရက်
Novartis finalizes new drug manufacturing facility in Morrisville, North Carolina
Profile
Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Novartis is one of the largest pharmaceutical companies in the world and was the eighth largest by revenue in 2024. Novartis manufactures the drugs clozapine, diclofenac, carbamazepine, valsartan, imatinib mesylate, cyclosporine, letrozole, methylphenidate, terbinafine, deferasirox, and others. Novartis was formed in 1996 by the merger of Ciba-Geigy and Sandoz. It was considered the largest corporate merger in history during that time. The pharmaceutical and agrochemical divisions of both companies formed Novartis as an independent entity. The name Novartis was based on the Latin terms, novae artes. After the merger, other Ciba-Geigy and Sandoz businesses were sold, or, like Ciba Specialty Chemicals, spun off as independent companies. The Sandoz brand disappeared for three years, but was revived in 2003 when Novartis consolidated its generic drugs businesses into a single subsidiary and named it Sandoz. Wikipedia
About Novartis
CEOVasant Narasimhan
Employees၇.၅၃ သောင်း
Founded၁၉၉၆ ဖေ ၂၉
Headquartersဘေဆဲလ်, Basel City, ဆွစ်ဇာလန်
Sector-
Websitenovartis.com
Last report
၂၀၂၆ ဧ ၂၈
Fiscal Period
Q1 2026
Normalized EPS / Estimate
၁.၉၉/ (၂.၀၈ est.)USD
-၄.၅၄%miss
Revenue / Estimate
ဋေ ၁.၃၅ ထ/ (ဋေ ၁.၃၅ ထ est.)USD
+၀.၃၃%beat
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glanceInsights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
၂၀၂၅ ဇွန်
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
Revenue
ဋေ ၁.၄၈ ထ
ဋေ ၁.၄၄ ထ
ဋေ ၁.၃၉ ထ
ဋေ ၁.၃၅ ထ
Cost of goods sold
၃၃၁.၉၀ ဋေ
၃၅၃.၅၀ ဋေ
၃၅၄.၂၀ ဋေ
၃၄၃.၈၀ ဋေ
Cost of revenue
၃၃၁.၉၀ ဋေ
၃၅၃.၅၀ ဋေ
၃၅၄.၂၀ ဋေ
၃၄၃.၈၀ ဋေ
Research and development expenses
၂၆၁.၆၀ ဋေ
၂၈၆.၄၀ ဋေ
၂၈၃.၇၀ ဋေ
၂၇၈.၅၀ ဋေ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၃၄၄.၁၀ ဋေ
၃၃၀.၄၀ ဋေ
၃၄၃.၆၀ ဋေ
၃၁၃.၇၀ ဋေ
Operating expense
၆၀၅.၃၀ ဋေ
၆၂၃.၈၀ ဋေ
၆၄၆.၃၀ ဋေ
၅၉၆.၄၀ ဋေ
Total operating expenses
၉၃၇.၂၀ ဋေ
၉၇၇.၃၀ ဋေ
ဋေ ၁.၀၀ ထ
၉၄၀.၂၀ ဋေ
Operating income
၅၄၆.၄၀ ဋေ
၄၅၈.၅၀ ဋေ
၃၈၅.၅၀ ဋေ
၄၁၂.၂၀ ဋေ
Other non operating income
-၁.၃၀ ကုဋေ
-၇.၀၀ သန်း
-၁၃.၀၀ ကုဋေ
၄.၀၀ သန်း
EBT including unusual items
၄၅၃.၁၀ ဋေ
၄၁၉.၆၀ ဋေ
၃၂၁.၈၀ ဋေ
၃၈၃.၉၀ ဋေ
EBT excluding unusual items
၅၁၅.၉၀ ဋေ
၄၂၉.၃၀ ဋေ
၃၄၉.၂၀ ဋေ
၃၇၈.၀၀ ဋေ
Income tax expense
၅၀.၇၀ ကုဋေ
၂၆.၆၀ ကုဋေ
၈၁.၄၀ ကုဋေ
၆၈.၃၀ ကုဋေ
Effective tax rate
၁၁.၁၉%
၆.၃၄%
၂၅.၃၀%
၁၇.၇၉%
Other operating expenses
-၄.၀၀ သန်း
၇.၀၀ ကုဋေ
၁၉.၀၀ ကုဋေ
၄.၂၀ ကုဋေ
Net income
၄၀၄.၁၀ ဋေ
၃၉၂.၈၀ ဋေ
၂၄၀.၉၀ ဋေ
၃၁၅.၆၀ ဋေ
Net profit margin
၂၇.၂၄%
၂၇.၃၆%
၁၇.၃၈%
၂၃.၃၄%
Earnings per share
၂.၄၂
၂.၂၅
၂.၀၃
၁.၉၉
Interest and investment income
-
-
၃၇.၃၀ ကုဋေ
-
Interest expense
-၂၈.၉၀ ကုဋေ
-၂၈.၁၀ ကုဋေ
-၃၀.၄၀ ကုဋေ
-၃၄.၃၀ ကုဋေ
Net interest expenses
-၂၈.၉၀ ကုဋေ
-၂၈.၁၀ ကုဋေ
၆.၉၀ ကုဋေ
-၃၄.၃၀ ကုဋေ
Depreciation and amortization charges
-
-
-
-
EBITDA
၆၅၅.၆၀ ဋေ
၅၇၇.၅၀ ဋေ
၄၉၅.၆၀ ဋေ
၅၂၃.၈၀ ဋေ
Gain or loss from assets sale
-၆.၇၀ ကုဋေ
၈.၁၀ ကုဋေ
၈.၀၀ ကုဋေ
-၁၅.၉၀ ကုဋေ
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer